170 related articles for article (PubMed ID: 11123499)
1. Lack of pharmacokinetic interaction between valproic acid and a traditional Chinese medicine, Paeoniae Radix, in healthy volunteers.
Chen LC; Chou MH; Lin MF; Yang LL
J Clin Pharm Ther; 2000 Dec; 25(6):453-9. PubMed ID: 11123499
[TBL] [Abstract][Full Text] [Related]
2. Effects of Paeoniae Radix, a traditional Chinese medicine, on the pharmacokinetics of phenytoin.
Chen LC; Chou MH; Lin MF; Yang LL
J Clin Pharm Ther; 2001 Aug; 26(4):271-8. PubMed ID: 11493369
[TBL] [Abstract][Full Text] [Related]
3. A Chinese herb formula decreases the monocarboxylate transporter-mediated absorption of valproic acid in rats.
Yu CP; Tsai SY; Kao LJ; Chao PD; Hou YC
Phytomedicine; 2013 May; 20(7):648-53. PubMed ID: 23462213
[TBL] [Abstract][Full Text] [Related]
4. Levetiracetam, a new antiepileptic agent: lack of in vitro and in vivo pharmacokinetic interaction with valproic acid.
Coupez R; Nicolas JM; Browne TR
Epilepsia; 2003 Feb; 44(2):171-8. PubMed ID: 12558570
[TBL] [Abstract][Full Text] [Related]
5. A single-dose, three-period, six-sequence crossover study comparing the bioavailability of solution, suspension, and enteric-coated tablets of magnesium valproate in healthy Mexican volunteers under fasting conditions.
Marcelín-Jiménez G; Angeles-Moreno AP; Contreras-Zavala L; Morales-Martínez M; Rivera-Espinosa L
Clin Ther; 2009 Sep; 31(9):2002-11. PubMed ID: 19843490
[TBL] [Abstract][Full Text] [Related]
6. Steady-state dispositions of valproate and diflunisal alone and coadministered to healthy volunteers.
Addison RS; Parker-Scott SL; Eadie MJ; Hooper WD; Dickinson RG
Eur J Clin Pharmacol; 2000 Dec; 56(9-10):715-21. PubMed ID: 11214782
[TBL] [Abstract][Full Text] [Related]
7. Effects of amoxicillin/clavulanic acid on the pharmacokinetics of valproic acid.
Lee SY; Huh W; Jung JA; Yoo HM; Ko JW; Kim JR
Drug Des Devel Ther; 2015; 9():4559-63. PubMed ID: 26309401
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic parameters of total and unbound valproic acid and their relationships to seizure control in epileptic children.
Panomvana Na Ayudhya D; Suwanmanee J; Visudtibhan A
Am J Ther; 2006; 13(3):211-7. PubMed ID: 16772762
[TBL] [Abstract][Full Text] [Related]
9. The influence of old age and enzyme inducing comedication on the pharmacokinetics of valproic acid at steady-state: A case-matched evaluation based on therapeutic drug monitoring data.
Fattore C; Messina S; Battino D; Croci D; Mamoli D; Perucca E
Epilepsy Res; 2006 Aug; 70(2-3):153-60. PubMed ID: 16730950
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of monocarboxylate transporter-mediated absorption of valproic acid by Gegen-Qinlian-Tang.
Liu HJ; Yu CP; Hsieh YW; Tsai SY; Hou YC
Am J Chin Med; 2013; 41(2):369-78. PubMed ID: 23548126
[TBL] [Abstract][Full Text] [Related]
11. Effect of cholestyramine resin on single dose valproate pharmacokinetics.
Malloy MJ; Ravis WR; Pennell AT; Diskin CJ
Int J Clin Pharmacol Ther; 1996 May; 34(5):208-11. PubMed ID: 8738857
[TBL] [Abstract][Full Text] [Related]
12. Increased apparent oral clearance of valproic acid during intake of combined contraceptive steroids in women with epilepsy.
Galimberti CA; Mazzucchelli I; Arbasino C; Canevini MP; Fattore C; Perucca E
Epilepsia; 2006 Sep; 47(9):1569-72. PubMed ID: 16981874
[TBL] [Abstract][Full Text] [Related]
13. Bioequivalence studies of a new valproic acid delayed-release capsule and divalproex sodium delayed-release tablet.
Garikipati V; Toops DS; Fang Q
Curr Med Res Opin; 2008 Jul; 24(7):1869-76. PubMed ID: 18593524
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic interactions between carbamazepine and the traditional Chinese medicine Paeoniae Radix.
Chen LC; Chen YF; Chou MH; Lin MF; Yang LL; Yen KY
Biol Pharm Bull; 2002 Apr; 25(4):532-5. PubMed ID: 11995940
[TBL] [Abstract][Full Text] [Related]
15. Drug treatment of epilepsy in elderly people: focus on valproic Acid.
Stephen LJ
Drugs Aging; 2003; 20(2):141-52. PubMed ID: 12534314
[TBL] [Abstract][Full Text] [Related]
16. Lack of pharmacokinetic interactions between steady-state zonisamide and valproic acid in patients with epilepsy.
Ragueneau-Majlessi I; Levy RH; Brodie M; Smith D; Shah J; Grundy JS
Clin Pharmacokinet; 2005; 44(5):517-23. PubMed ID: 15871637
[TBL] [Abstract][Full Text] [Related]
17. Circadian variation of Valproic acid pharmacokinetics in mice.
Ben-Cherif W; Dridi I; Aouam K; Ben-Attia M; Reinberg A; Boughattas NA
Eur J Pharm Sci; 2013 Jul; 49(4):468-73. PubMed ID: 23707469
[TBL] [Abstract][Full Text] [Related]
18. Conventional and sustained-release valproate in children with newly diagnosed epilepsy: a randomized and crossover study comparing clinical effects, patient preference and pharmacokinetics.
Herranz JL; Arteaga R; Adín J; Armijo JA
Eur J Clin Pharmacol; 2006 Oct; 62(10):805-15. PubMed ID: 16896786
[TBL] [Abstract][Full Text] [Related]
19. A population pharmacokinetic model of valproic acid in pediatric patients with epilepsy: a non-linear pharmacokinetic model based on protein-binding saturation.
Ding J; Wang Y; Lin W; Wang C; Zhao L; Li X; Zhao Z; Miao L; Jiao Z
Clin Pharmacokinet; 2015 Mar; 54(3):305-17. PubMed ID: 25388986
[TBL] [Abstract][Full Text] [Related]
20. Population pharmacokinetics of valproic acid in epileptic children: Effects of clinical and genetic factors.
Xu S; Chen Y; Zhao M; Guo Y; Wang Z; Zhao L
Eur J Pharm Sci; 2018 Sep; 122():170-178. PubMed ID: 29981400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
